
NYSE:MOH
This summary was created by AI, based on 1 opinions in the last 12 months.
Molina Healthcare (MOH-N) has had a challenging year, illustrated by its significant decline of 55%, indicating ongoing struggles in its operational and market performance. A critical factor contributing to this downturn is the company's high exposure to government programs like Medicare and Medicaid, which could be influencing its profitability and growth potential. Furthermore, Molina Healthcare is set to leave the S&P index, which typically raises concerns among investors about its stability and long-term prospects. Overall, these factors highlight the company's vulnerabilities in a competitive healthcare landscape and necessitate careful consideration by potential investors before committing capital.
Molina Healthcare is a American stock, trading under the symbol MOH (previously MOH-N on Stockchase) on the New York Stock Exchange (MOH). It is usually referred to as NYSE:MOH or MOH
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MOH (previously MOH-N on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Molina Healthcare.
Molina Healthcare was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Molina Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Molina Healthcare.
Molina Healthcare is covered by Stockchase experts and is worth watching.
On 2026-07-02, Molina Healthcare (MOH) stock closed at a price of $229.87.
Is -55% the past year. Very exposed to Medicare and Medicaid. Is leaving the S&P.